Company profile
Apaxen company profile
Apaxen is a company that creates anti-inflammatory medicines to treat pulmonary arterial hypertension. The business focuses on finding and creating suitable small molecule inhibitors of macrophage migration inhibitory factor, which is essential for the creation and activation of NLRP3 inflammasomes. Its drug candidate, MFC-1040, is an orally bioavailable and selective small-molecule MIF inhibitor that is being developed to treat pulmonary arterial hypertension, a deadly illness with a medical need because current treatments are symptomatic and have a low median survival rate.
Business identity
- Website
- https://www.apaxen.com
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0+
- Founded
- 2018-01-01, Year
Headquarters
- Headquarters
- Gozée, Wallonia, Belgium
- Postal code
- 6041
- Country code
- BE
- Continent
- Europe